aluates Reports

$ 0.0

Automative

Global Small Molecule Drug Conjugates (SMDCs) Market Research Report 2026

Published Date: 2026-01-29

Report Code: QYRE-Auto-37G18410

Global Small Molecule Drug Conjugates SMDCs Market Research Report 2024

BUY CHAPTERS

Global Small Molecule Drug Conjugates (SMDCs) Market Research Report 2026

Code: QYRE-Auto-37G18410

Report

2026-01-29

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

SciClone

Tarveda Therapeutics

Conway

Daiichi Sankyo

Bristol–Myers Squibb

Cidara Therapeutics

Yafei (Shanghai) Biomedical Technology (Affinity)

Vincerx Pharma

Novartis(Endocyte)

Ascentawits Pharmaceuticals

Coherent Biopharma Suzhou Co

Small Molecule Drug Conjugates (SMDCs) Market

The global Small Molecule Drug Conjugates (SMDCs) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Small Molecule Drug Conjugates (SMDCs) are a class of drugs that combine small molecule drugs with other biologically active molecules by chemical means. This combination can improve the targeting of drugs, enhance their efficacy, and reduce systemic toxicity.

The North American market for Small Molecule Drug Conjugates (SMDCs) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Small Molecule Drug Conjugates (SMDCs) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Small Molecule Drug Conjugates (SMDCs) in Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Small Molecule Drug Conjugates (SMDCs) include SciClone, Tarveda Therapeutics, Yafei (Shanghai) Biomedical Technology (Affinity), Vincerx Pharma, Novartis(Endocyte), Ascentawits Pharmaceuticals, Conway, Daiichi Sankyo, Bristol Myers Squibb, Cidara Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Small Molecule Drug Conjugates (SMDCs) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Small Molecule Drug Conjugates (SMDCs). The Small Molecule Drug Conjugates (SMDCs) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Small Molecule Drug Conjugates (SMDCs) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Small Molecule Drug Conjugates (SMDCs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Small Molecule Drug Conjugates (SMDCs) Market Report

Report Metric	Details
Report Name	Small Molecule Drug Conjugates (SMDCs) Market
Segment by Type	PSMA FOLR1 FAP Other
Segment by Application	Cancer Urogenital Diseases Digestive Diseases Skin and Musculoskeletal Diseases Endocrine and Metabolic Diseases Respiratory Diseases Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	SciClone, Tarveda Therapeutics, Yafei (Shanghai) Biomedical Technology (Affinity), Vincerx Pharma, Novartis(Endocyte), Ascentawits Pharmaceuticals, Conway, Daiichi Sankyo, Bristol Myers Squibb, Cidara Therapeutics, Coherent Biopharma Suzhou Co
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Small Molecule Drug Conjugates (SMDCs) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Small Molecule Drug Conjugates (SMDCs) Market report?

Ans: The main players in the Small Molecule Drug Conjugates (SMDCs) Market are SciClone, Tarveda Therapeutics, Yafei (Shanghai) Biomedical Technology (Affinity), Vincerx Pharma, Novartis(Endocyte), Ascentawits Pharmaceuticals, Conway, Daiichi Sankyo, Bristol Myers Squibb, Cidara Therapeutics, Coherent Biopharma Suzhou Co

What are the Application segmentation covered in the Small Molecule Drug Conjugates (SMDCs) Market report?

Ans: The Applications covered in the Small Molecule Drug Conjugates (SMDCs) Market report are Cancer, Urogenital Diseases, Digestive Diseases, Skin and Musculoskeletal Diseases, Endocrine and Metabolic Diseases, Respiratory Diseases, Other

What are the Type segmentation covered in the Small Molecule Drug Conjugates (SMDCs) Market report?

Ans: The Types covered in the Small Molecule Drug Conjugates (SMDCs) Market report are PSMA, FOLR1, FAP, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 PSMA

1.2.3 FOLR1

1.2.4 FAP

1.2.5 Other

1.3 Market by Application

1.3.1 Global Small Molecule Drug Conjugates (SMDCs) Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Cancer

1.3.3 Urogenital Diseases

1.3.4 Digestive Diseases

1.3.5 Skin and Musculoskeletal Diseases

1.3.6 Endocrine and Metabolic Diseases

1.3.7 Respiratory Diseases

1.3.8 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Perspective (2021–2032)

2.2 Global Small Molecule Drug Conjugates (SMDCs) Growth Trends by Region

2.2.1 Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Region (2021–2026)

2.2.3 Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Region (2027–2032)

2.3 Small Molecule Drug Conjugates (SMDCs) Market Dynamics

2.3.1 Small Molecule Drug Conjugates (SMDCs) Industry Trends

2.3.2 Small Molecule Drug Conjugates (SMDCs) Market Drivers

2.3.3 Small Molecule Drug Conjugates (SMDCs) Market Challenges

2.3.4 Small Molecule Drug Conjugates (SMDCs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Small Molecule Drug Conjugates (SMDCs) Players by Revenue

3.1.1 Global Top Small Molecule Drug Conjugates (SMDCs) Players by Revenue (2021–2026)

3.1.2 Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Players (2021–2026)

3.2 Global Top Small Molecule Drug Conjugates (SMDCs) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Small Molecule Drug Conjugates (SMDCs) Revenue

3.4 Global Small Molecule Drug Conjugates (SMDCs) Market Concentration Ratio

3.4.1 Global Small Molecule Drug Conjugates (SMDCs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug Conjugates (SMDCs) Revenue in 2025

3.5 Global Key Players of Small Molecule Drug Conjugates (SMDCs) Head Offices and Areas Served

3.6 Global Key Players of Small Molecule Drug Conjugates (SMDCs), Products and Applications

3.7 Global Key Players of Small Molecule Drug Conjugates (SMDCs), Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Small Molecule Drug Conjugates (SMDCs) Breakdown Data by Type

4.1 Global Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Type (2021–2026)

4.2 Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Type (2027–2032)

5 Small Molecule Drug Conjugates (SMDCs) Breakdown Data by Application

5.1 Global Small Molecule Drug Conjugates (SMDCs) Historic Market Size by Application (2021–2026)

5.2 Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)

6.2 North America Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)

6.4 North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)

7.2 Europe Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)

7.4 Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)

8.2 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (2021–2026)

8.4 Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)

9.2 Latin America Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)

9.4 Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size (2021–2032)

10.2 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2021–2026)

10.4 Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 SciClone

11.1.1 SciClone Company Details

11.1.2 SciClone Business Overview

11.1.3 SciClone Small Molecule Drug Conjugates (SMDCs) Introduction

11.1.4 SciClone Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.1.5 SciClone Recent Development

11.2 Tarveda Therapeutics

11.2.1 Tarveda Therapeutics Company Details

11.2.2 Tarveda Therapeutics Business Overview

11.2.3 Tarveda Therapeutics Small Molecule Drug Conjugates (SMDCs) Introduction

11.2.4 Tarveda Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.2.5 Tarveda Therapeutics Recent Development

11.3 Yafei (Shanghai) Biomedical Technology (Affinity)

11.3.1 Yafei (Shanghai) Biomedical Technology (Affinity) Company Details

11.3.2 Yafei (Shanghai) Biomedical Technology (Affinity) Business Overview

11.3.3 Yafei (Shanghai) Biomedical Technology (Affinity) Small Molecule Drug Conjugates (SMDCs) Introduction

11.3.4 Yafei (Shanghai) Biomedical Technology (Affinity) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.3.5 Yafei (Shanghai) Biomedical Technology (Affinity) Recent Development

11.4 Vincerx Pharma

11.4.1 Vincerx Pharma Company Details

11.4.2 Vincerx Pharma Business Overview

11.4.3 Vincerx Pharma Small Molecule Drug Conjugates (SMDCs) Introduction

11.4.4 Vincerx Pharma Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.4.5 Vincerx Pharma Recent Development

11.5 Novartis(Endocyte)

11.5.1 Novartis(Endocyte) Company Details

11.5.2 Novartis(Endocyte) Business Overview

11.5.3 Novartis(Endocyte) Small Molecule Drug Conjugates (SMDCs) Introduction

11.5.4 Novartis(Endocyte) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.5.5 Novartis(Endocyte) Recent Development

11.6 Ascentawits Pharmaceuticals

11.6.1 Ascentawits Pharmaceuticals Company Details

11.6.2 Ascentawits Pharmaceuticals Business Overview

11.6.3 Ascentawits Pharmaceuticals Small Molecule Drug Conjugates (SMDCs) Introduction

11.6.4 Ascentawits Pharmaceuticals Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.6.5 Ascentawits Pharmaceuticals Recent Development

11.7 Conway

11.7.1 Conway Company Details

11.7.2 Conway Business Overview

11.7.3 Conway Small Molecule Drug Conjugates (SMDCs) Introduction

11.7.4 Conway Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.7.5 Conway Recent Development

11.8 Daiichi Sankyo

11.8.1 Daiichi Sankyo Company Details

11.8.2 Daiichi Sankyo Business Overview

11.8.3 Daiichi Sankyo Small Molecule Drug Conjugates (SMDCs) Introduction

11.8.4 Daiichi Sankyo Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.8.5 Daiichi Sankyo Recent Development

11.9 Bristol Myers Squibb

11.9.1 Bristol Myers Squibb Company Details

11.9.2 Bristol Myers Squibb Business Overview

11.9.3 Bristol Myers Squibb Small Molecule Drug Conjugates (SMDCs) Introduction

11.9.4 Bristol Myers Squibb Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.9.5 Bristol Myers Squibb Recent Development

11.10 Cidara Therapeutics

11.10.1 Cidara Therapeutics Company Details

11.10.2 Cidara Therapeutics Business Overview

11.10.3 Cidara Therapeutics Small Molecule Drug Conjugates (SMDCs) Introduction

11.10.4 Cidara Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.10.5 Cidara Therapeutics Recent Development

11.11 Coherent Biopharma Suzhou Co

11.11.1 Coherent Biopharma Suzhou Co Company Details

11.11.2 Coherent Biopharma Suzhou Co Business Overview

11.11.3 Coherent Biopharma Suzhou Co Small Molecule Drug Conjugates (SMDCs) Introduction

11.11.4 Coherent Biopharma Suzhou Co Revenue in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

11.11.5 Coherent Biopharma Suzhou Co Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

SciClone

Tarveda Therapeutics

Conway

Daiichi Sankyo

Bristol–Myers Squibb

Cidara Therapeutics

Yafei (Shanghai) Biomedical Technology (Affinity)

Vincerx Pharma

Novartis(Endocyte)

Ascentawits Pharmaceuticals

Coherent Biopharma Suzhou Co

List of Tables

Table 1. Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of PSMA

Table 3. Key Players of FOLR1

Table 4. Key Players of FAP

Table 5. Key Players of Other

Table 6. Global Small Molecule Drug Conjugates (SMDCs) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2021–2026

Table 9. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2021–2026)

Table 10. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2027–2032)

Table 12. Small Molecule Drug Conjugates (SMDCs) Market Trends

Table 13. Small Molecule Drug Conjugates (SMDCs) Market Drivers

Table 14. Small Molecule Drug Conjugates (SMDCs) Market Challenges

Table 15. Small Molecule Drug Conjugates (SMDCs) Market Restraints

Table 16. Global Small Molecule Drug Conjugates (SMDCs) Revenue by Players (US$ Million), 2021–2026

Table 17. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Players (2021–2026)

Table 18. Global Top Small Molecule Drug Conjugates (SMDCs) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Small Molecule Drug Conjugates (SMDCs) Revenue, 2025

Table 19. Ranking of Global Top Small Molecule Drug Conjugates (SMDCs) Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Small Molecule Drug Conjugates (SMDCs) Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Headquarters and Area Served

Table 22. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Products and Applications

Table 23. Global Key Players of Small Molecule Drug Conjugates (SMDCs), Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Type (US$ Million), 2021–2026

Table 26. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Type (2021–2026)

Table 27. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Type (2027–2032)

Table 29. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Application (US$ Million), 2021–2026

Table 30. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Application (2021–2026)

Table 31. Global Small Molecule Drug Conjugates (SMDCs) Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Small Molecule Drug Conjugates (SMDCs) Revenue Market Share by Application (2027–2032)

Table 33. North America Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026

Table 35. North America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size by Country (US$ Million), 2027–2032

Table 48. SciClone Company Details

Table 49. SciClone Business Overview

Table 50. SciClone Small Molecule Drug Conjugates (SMDCs) Product

Table 51. SciClone Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 52. SciClone Recent Development

Table 53. Tarveda Therapeutics Company Details

Table 54. Tarveda Therapeutics Business Overview

Table 55. Tarveda Therapeutics Small Molecule Drug Conjugates (SMDCs) Product

Table 56. Tarveda Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 57. Tarveda Therapeutics Recent Development

Table 58. Yafei (Shanghai) Biomedical Technology (Affinity) Company Details

Table 59. Yafei (Shanghai) Biomedical Technology (Affinity) Business Overview

Table 60. Yafei (Shanghai) Biomedical Technology (Affinity) Small Molecule Drug Conjugates (SMDCs) Product

Table 61. Yafei (Shanghai) Biomedical Technology (Affinity) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 62. Yafei (Shanghai) Biomedical Technology (Affinity) Recent Development

Table 63. Vincerx Pharma Company Details

Table 64. Vincerx Pharma Business Overview

Table 65. Vincerx Pharma Small Molecule Drug Conjugates (SMDCs) Product

Table 66. Vincerx Pharma Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 67. Vincerx Pharma Recent Development

Table 68. Novartis(Endocyte) Company Details

Table 69. Novartis(Endocyte) Business Overview

Table 70. Novartis(Endocyte) Small Molecule Drug Conjugates (SMDCs) Product

Table 71. Novartis(Endocyte) Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 72. Novartis(Endocyte) Recent Development

Table 73. Ascentawits Pharmaceuticals Company Details

Table 74. Ascentawits Pharmaceuticals Business Overview

Table 75. Ascentawits Pharmaceuticals Small Molecule Drug Conjugates (SMDCs) Product

Table 76. Ascentawits Pharmaceuticals Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 77. Ascentawits Pharmaceuticals Recent Development

Table 78. Conway Company Details

Table 79. Conway Business Overview

Table 80. Conway Small Molecule Drug Conjugates (SMDCs) Product

Table 81. Conway Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 82. Conway Recent Development

Table 83. Daiichi Sankyo Company Details

Table 84. Daiichi Sankyo Business Overview

Table 85. Daiichi Sankyo Small Molecule Drug Conjugates (SMDCs) Product

Table 86. Daiichi Sankyo Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 87. Daiichi Sankyo Recent Development

Table 88. Bristol Myers Squibb Company Details

Table 89. Bristol Myers Squibb Business Overview

Table 90. Bristol Myers Squibb Small Molecule Drug Conjugates (SMDCs) Product

Table 91. Bristol Myers Squibb Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 92. Bristol Myers Squibb Recent Development

Table 93. Cidara Therapeutics Company Details

Table 94. Cidara Therapeutics Business Overview

Table 95. Cidara Therapeutics Small Molecule Drug Conjugates (SMDCs) Product

Table 96. Cidara Therapeutics Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 97. Cidara Therapeutics Recent Development

Table 98. Coherent Biopharma Suzhou Co Company Details

Table 99. Coherent Biopharma Suzhou Co Business Overview

Table 100. Coherent Biopharma Suzhou Co Small Molecule Drug Conjugates (SMDCs) Product

Table 101. Coherent Biopharma Suzhou Co Revenue in Small Molecule Drug Conjugates (SMDCs) Business (US$ Million), 2021–2026

Table 102. Coherent Biopharma Suzhou Co Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Small Molecule Drug Conjugates (SMDCs) Picture

Figure 2. Global Small Molecule Drug Conjugates (SMDCs) Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Type: 2025 vs 2032

Figure 4. PSMA Features

Figure 5. FOLR1 Features

Figure 6. FAP Features

Figure 7. Other Features

Figure 8. Global Small Molecule Drug Conjugates (SMDCs) Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Application: 2025 vs 2032

Figure 10. Cancer Case Studies

Figure 11. Urogenital Diseases Case Studies

Figure 12. Digestive Diseases Case Studies

Figure 13. Skin and Musculoskeletal Diseases Case Studies

Figure 14. Endocrine and Metabolic Diseases Case Studies

Figure 15. Respiratory Diseases Case Studies

Figure 16. Other Case Studies

Figure 17. Small Molecule Drug Conjugates (SMDCs) Report Years Considered

Figure 18. Global Small Molecule Drug Conjugates (SMDCs) Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 19. Global Small Molecule Drug Conjugates (SMDCs) Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 20. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Region: 2025 vs 2032

Figure 21. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Players in 2025

Figure 22. Global Small Molecule Drug Conjugates (SMDCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. The Top 10 and 5 Players Market Share by Small Molecule Drug Conjugates (SMDCs) Revenue in 2025

Figure 24. North America Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. North America Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)

Figure 26. United States Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Canada Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Europe Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)

Figure 30. Germany Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. France Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. U.K. Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Italy Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Russia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Ireland Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Asia-Pacific Small Molecule Drug Conjugates (SMDCs) Market Share by Region (2021–2032)

Figure 38. China Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Japan Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. South Korea Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Southeast Asia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. India Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Australia & New Zealand Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Latin America Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)

Figure 46. Mexico Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Brazil Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Middle East & Africa Small Molecule Drug Conjugates (SMDCs) Market Share by Country (2021–2032)

Figure 50. Israel Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Saudi Arabia Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. UAE Small Molecule Drug Conjugates (SMDCs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. SciClone Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 54. Tarveda Therapeutics Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 55. Yafei (Shanghai) Biomedical Technology (Affinity) Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 56. Vincerx Pharma Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 57. Novartis(Endocyte) Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 58. Ascentawits Pharmaceuticals Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 59. Conway Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 60. Daiichi Sankyo Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 61. Bristol Myers Squibb Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 62. Cidara Therapeutics Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 63. Coherent Biopharma Suzhou Co Revenue Growth Rate in Small Molecule Drug Conjugates (SMDCs) Business (2021–2026)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antibody drug Conjugates for Tumors Market Research Report 2024

Global Small Molecule CMC Service Market Research Report 2024

Global Small Molecule Drug Design Software Market Research Report 2024

Global Small Molecule Analytical Service Market Research Report 2024

Global Small Molecules CDMO Services Market Research Report 2024

Small Molecule Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibody drug Conjugates Market Insights Forecast to 2030

Global Small Molecule Liquid Chromatography System Market Research Report 2024

Global Aptamer Drug Conjugates ApDC Market Research Report 2024

Global Small Molecule Drug 3D Printing Market Research Report 2024

Small Molecule Prefilled Syringes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule Chromatography System Market Research Report 2024

Global RNA Targeted Small Molecules Market Research Report 2024

Global Small Molecule Targeted Cancer Therapy Market Research Report 2025

Global Commercialized Small Molecule for Therapy Market Research Report 2024

Antibody drug Conjugate for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecule API Development Service Market Research Report 2025

Global Antibody drug Conjugates ADCs CMO and CDMO Market Research Report 2025

Global Small Molecule API and Intermediates Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions